MitraClip sets a new standard for TEER therapy based on the EXPAND G4 data in Japan

Sponsored by Abbott

Summary

This video discusses the results of the Expand G4 trial conducted in Japan, focusing on the use of MitraClip for transcatheter edge-to-edge repair therapy. Interviewed by Mike Saji, Masahiko Asami presents data showing a high success rate in Japanese patients, with significant reductions in mitral regurgitation after one year. The interview also touches on the potential future direction of MitraClip therapy and the importance of considering earlier intervention for patients with MR symptoms.

This interview was filmed at PCR Tokyo Valves 2024: see more videos here.